Development of lipid nanoparticles for transdermal loteprednol etabonate delivery

Abstract Aim Loteprednol etabonate (LE) is a new generation corticosteroid that is used for the treatment of inflammatory and allergic conditions of the eye. Therefore, solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) were attempted to improve transdermal LE delivery for the first time. Methods SLN and NLC were produced by hot homogenisation and ultrasonication technique. Their physical stability was monitored for 3 months of storage. Drug release and permeation of SLN and NLC through the porcine skin were investigated. Results It was determined that SLN and NLC mean particle size of 139.1 nm had a homogeneous particle size distribution (∼0.169 PI) and the mean charge was −23.6. They were found to be stable both physically and chemically at room temperature. Conclusion SLN and NLC formulations of LE can be stated among the systems that can be an alternative to conventional systems with fewer side-effects in the treatment of inflammatory problems.

[1]  Maelíosa T. C. McCrudden,et al.  Enhancement strategies for transdermal drug delivery systems: current trends and applications , 2021, Drug Delivery and Translational Research.

[2]  S. Souto,et al.  Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity , 2020, Molecules.

[3]  M. Ergüven,et al.  Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia. , 2019, Materials science & engineering. C, Materials for biological applications.

[4]  M. Cavet,et al.  Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies , 2019, Clinical ophthalmology.

[5]  M. H. Santana,et al.  Evaluation of the Influence of Process Parameters on the Properties of Resveratrol-Loaded NLC Using 22 Full Factorial Design , 2019, Antioxidants.

[6]  M. Khaleel,et al.  Natamycin solid lipid nanoparticles – sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization , 2019, International journal of nanomedicine.

[7]  A. M. Cornélio,et al.  Tailoring structural properties of spray-dried methotrexate-loaded poly (lactic acid)/poloxamer microparticle blends , 2019, Journal of Materials Science: Materials in Medicine.

[8]  P. Bhide,et al.  FORMULATION AND EVALUATION OF SOLUBILITY ENHANCED IN SITU GELLING EYE DROPS OF LOTEPREDNOL ETABONATE , 2019 .

[9]  Karthik Yadav Janga,et al.  In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies , 2018, Nanomaterials.

[10]  J. M. Marchetti,et al.  Skin permeation, biocompatibility and antitumor effect of chloroaluminum phthalocyanine associated to oleic acid in lipid nanoparticles. , 2018, Photodiagnosis and photodynamic therapy.

[11]  E. Kahraman,et al.  The combination of nanomicelles with terpenes for enhancement of skin drug delivery , 2018, International journal of pharmaceutics.

[12]  M. Abdel-Bakky,et al.  Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation , 2018, International journal of pharmaceutics.

[13]  Leonardo Fernandes Fraceto,et al.  Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.

[14]  G. Duman,et al.  Eplerenone nanoemulsions for treatment of hypertension. Part I: Experimental design for optimization of formulations and physical characterization , 2018 .

[15]  J. Sheppard,et al.  Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid , 2018, Expert opinion on pharmacotherapy.

[16]  Anupam Das,et al.  Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach , 2017, Indian journal of dermatology.

[17]  J. Bugert,et al.  Anti‐inflammatory activity of Punica granatum L. (Pomegranate) rind extracts applied topically to ex vivo skin , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  A. Madgulkar,et al.  Formulation and characterization of solid lipid nanoparticles for an anti-retroviral drug darunavir , 2017, Applied Nanoscience.

[19]  L. B. Lopes,et al.  Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel , 2016, International journal of nanomedicine.

[20]  A. Calpena,et al.  Ex vivo permeation of carprofen from nanoparticles: A comprehensive study through human, porcine and bovine skin as anti-inflammatory agent. , 2016, International journal of pharmaceutics.

[21]  Vandana Gupta,et al.  Ex vivo localization and permeation of cisplatin from novel topical formulations through excised pig, goat, and mice skin and in vitro characterization for effective management of skin-cited malignancies , 2015, Artificial cells, nanomedicine, and biotechnology.

[22]  H. Valizadeh,et al.  Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application. , 2015, Advanced pharmaceutical bulletin.

[23]  Y. Han,et al.  A validated specific stability-indicating RP-HPLC assay method for the determination of loteprednol etabonate in eye drops. , 2015, Journal of chromatographic science.

[24]  F. M. Musteata,et al.  Investigating Transdermal Delivery of Vitamin D3 , 2015, AAPS PharmSciTech.

[25]  S. M. Badr-Eldin,et al.  Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals , 2014, Expert opinion on drug delivery.

[26]  E. Karaman,et al.  Solid Lipid Nanoparticles and Nanostructured Lipid Carriers of Loratadine for Topical Application: Physicochemical Stability and Drug Penetration through Rat Skin , 2014 .

[27]  A. Attama,et al.  Nanoparticles for Dermal and Transdermal Drug Delivery , 2014 .

[28]  G. Yener,et al.  Solid Lipid Nanoparticles and Nanostructured Lipid Carriers of Celecoxib for Topical Application - Preparation, Characterization and Drug Penetration Through Rat Skin , 2014 .

[29]  M. Nagarsenker,et al.  Simvastatin Solid Lipid Nanoparticles for Oral Delivery: Formulation Development and In vivo Evaluation , 2013, Indian journal of pharmaceutical sciences.

[30]  D. Das,et al.  Influence of array interspacing on the force required for successful microneedle skin penetration: theoretical and practical approaches. , 2013, Journal of pharmaceutical sciences.

[31]  A. Attama,et al.  Lipid Nanoparticulate Drug Delivery Systems: A Revolution in Dosage Form Design and Development , 2012 .

[32]  S. Rathi,et al.  Rational and Ethical Use of Topical Corticosteroids Based on Safety and Efficacy , 2012, Indian journal of dermatology.

[33]  M. Busin,et al.  Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use , 2012, International Ophthalmology.

[34]  S. Fatemi,et al.  Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. , 2012, International journal of pharmaceutics.

[35]  Stuart Noble,et al.  Loteprednol Etabonate , 1998, BioDrugs.

[36]  H. M. Nielsen,et al.  In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[37]  Shiow-Fern Ng,et al.  A Comparative Study of Transmembrane Diffusion and Permeation of Ibuprofen across Synthetic Membranes Using Franz Diffusion Cells , 2010, Pharmaceutics.

[38]  Qiang Zhang,et al.  Preparation and characterization of silybin-loaded nanostructured lipid carriers , 2010, Drug delivery.

[39]  H. Korting,et al.  Carriers in the topical treatment of skin disease. , 2010, Handbook of experimental pharmacology.

[40]  N. V. Selivanova,et al.  Stabilization of the oleic acid-water emulsion with various kraft lignins , 2008 .

[41]  S. Hou,et al.  [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window]. , 2008, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[42]  A. Almeida,et al.  Lipid nanoparticles (SLN (R), NLC (R)) for cutaneous drug delivery , 2007 .

[43]  H. Korting,et al.  The pH of the Skin Surface and Its Impact on the Barrier Function , 2006, Skin Pharmacology and Physiology.

[44]  R. Jerome,et al.  Polylactide Microparticles Prepared by Double Emulsion/Evaporation Technique. I. Effect of Primary Emulsion Stability , 1994, Pharmaceutical Research.

[45]  S. Wissing,et al.  Investigations on the occlusive properties of solid lipid nanoparticles (SLN). , 2001, Journal of cosmetic science.

[46]  K. Goa,et al.  Loteprednol etabonate: clinical potential in the management of ocular inflammation. , 1998, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[47]  K. Westesen,et al.  Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles , 1994 .

[48]  M. Takahashi,et al.  Effect of cetostearyl alcohol on stabilization of oil-in-water emulsion:I. Difference in the effect by mixing cetyl alcohol with stearyl alcohol , 1976 .